These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32506319)

  • 21. AML with inv(16) with numerous Charcot-Leyden crystals.
    Dwyre DM; Osman M
    Blood; 2019 Nov; 134(21):1876. PubMed ID: 31751481
    [No Abstract]   [Full Text] [Related]  

  • 22. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
    Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
    Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute myeloid leukemia with inversion of chromosome 16: cytological, immunophenotypic and cytogenetic disruption].
    Mghinia S; Zaidani M; Hda N; Gamraoui K; Oukkache B
    Ann Biol Clin (Paris); 2020 Apr; 78(2):187-190. PubMed ID: 32319947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia.
    Myint H; Ross FM; Hall JL; Hamblin TJ
    Leuk Res; 1997 May; 21(5):473-4. PubMed ID: 9225078
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
    Min GJ; Kim HJ; Yoon JH; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of trisomy 22 and inversion 16 in acute myeloid leukemia].
    Zhou HF; Li JY; Pan JL; Qiu HR; Chen LJ; Hu JY; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):11-4. PubMed ID: 17649718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia.
    Kim HG; LeGrand J; Swindle CS; Nick HJ; Oster RA; Chen D; Purohit-Ghelani S; Cotta CV; Ko R; Gartland L; Reddy V; Hiebert SW; Friedman AD; Klug CA
    Leukemia; 2017 Oct; 31(10):2267-2271. PubMed ID: 28751774
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffuse pulmonary alveolar hemorrhage in acute promyelocytic leukemia.
    Saka H; Ito T; Ito M; Watanabe A; Shimokata K
    Intern Med; 1992 Apr; 31(4):457-8. PubMed ID: 1633346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of Inversion 16 in TKD Positive and Negative Acute Myeloid Leukemia Patients.
    Shahab S; Zahid D; Ahmed S; Nadeem M; Farzana T; Taj M; Ahmed N; Shamsi TS
    Asian Pac J Cancer Prev; 2016; 17(4):2343-4. PubMed ID: 27221943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of massive pulmonary hemorrhage in acute leukemia.
    Smith LJ; Katzenstein AL
    Arch Intern Med; 1982 Nov; 142(12):2149-52. PubMed ID: 6958217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of therapy-related acute myeloid leukemia associated with inv(16)].
    Lee SY; Kim M; Lim J; Kim Y; Han K; Kim SY; Kim HJ; Park IY
    Korean J Lab Med; 2007 Feb; 27(1):19-21. PubMed ID: 18094545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient.
    Du EZ; Yung GL; Le DT; Masliah E; Yi ES; Friedman PJ
    J Thorac Imaging; 2001 Oct; 16(4):307-9. PubMed ID: 11685098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience.
    Razzouk BI; Raimondi SC; Srivastava DK; Pritchard M; Behm FG; Tong X; Sandlund JT; Rubnitz JE; Pui CH; Ribeiro RC
    Leukemia; 2001 Sep; 15(9):1326-30. PubMed ID: 11516092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).
    Joseph R; McRee AJ; Mathews S; Zeidner JF
    Leuk Lymphoma; 2019 Nov; 60(11):2793-2797. PubMed ID: 31119961
    [No Abstract]   [Full Text] [Related]  

  • 36. Diffuse alveolar hemorrhage: a nonthrombotic antiphospholipid lung syndrome?
    Asherson RA; Cervera R; Wells AU
    Semin Arthritis Rheum; 2005 Dec; 35(3):138-42. PubMed ID: 16325654
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluorescence in situ hybridization identifies inversion 16 masked by t(10;16)(q24;q22), t(7;16)(q21;q22), and t(2;16)(q37;q22) in three cases of AML-M4Eo.
    Reddy KS; Wang S; Montgomery P; Grove W; Robertson LE
    Cancer Genet Cytogenet; 2000 Jan; 116(2):148-52. PubMed ID: 10640147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related leukemia with Inv(16)(p13.1q22) and type D CBFB/MYH11 developing after exposure to irinotecan-containing chemoradiotherapy.
    Akiyama H; Yamamoto M; Sakashita C; Umezawa Y; Kurosu T; Murakami N; Miura O
    Intern Med; 2015; 54(6):651-5. PubMed ID: 25786458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16).
    Chaffanet M; Mozziconacci MJ; Fernandez F; Sainty D; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Genes Chromosomes Cancer; 1999 Oct; 26(2):161-5. PubMed ID: 10469454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.